Icon close

Close

People

Jennifer Stewart is a senior associate in King & Spalding’s Mass Tort and Toxic Tort and Product Liability practices. Jennifer defends Fortune 100 and other large companies in a wide range of complex litigation matters, including pharmaceutical and other product liability, toxic tort and commercial cases. She also has significant deposition, motion, case management and trial experience.

King & Spalding's Tort Litigation practice was selected by The American Lawyer in 2012 as one of the top three in the United States, and the Product Liability practice was selected by Law360 in 2014 as one of the top five in the United States.

Prior to joining King & Spalding, Jennifer spent several years as an associate at a business litigation firm in New York City, where she was a member of litigation and trial teams, defending Fortune 100 companies in product liability and toxic tort cases.

Jennifer obtained her Juris Doctor from The Catholic University of America, Columbus School of Law. In law school, she served as the senior note and comment editor for the Commlaw Conspectus: Journal of Communications Law and Policy.

 

Full Bio

Credentials

J.D., Columbus School of Law

B.A., Boston University, cum laude

California

New Jersey

New York

U.S. District Court for the Central District of California

U.S. District Court for the District of New Jersey

U.S. District Court for the Southern District of New York

News

In the News · Source: Law.com, The Global Legal Post, Global Arbitration Review, IJGlobal, The Deal, Law360 Pulse, Australasian Lawyer, The Daily Report, Le Monde du Droit and La Lettre des Juristes d'Affaires

December 8, 2022
K&S elects 24 new partners and promotes 17 counsel across 15 cities

View all

Matters

Represents AstraZeneca Pharmaceuticals LP in coordinated California state court product liability cases related to treatment with Crestor®. 

Defends Bristol-Myers Squibb Company and AstraZeneca Pharmaceuticals LP in litigation in state and federal courts related to treatment with Onglyza®, a type 2 diabetes therapy.

Represented Fortune 100 companies in products matters involving alleged harm as a result of exposure to asbestos.  Jennifer has experience in handling all aspects of these cases and, as such, has secured dismissals or favorable settlements for her clients. 

See more
Icon close

Close

Matters

Represents AstraZeneca Pharmaceuticals LP in coordinated California state court product liability cases related to treatment with Crestor®. 

Defends Bristol-Myers Squibb Company and AstraZeneca Pharmaceuticals LP in litigation in state and federal courts related to treatment with Onglyza®, a type 2 diabetes therapy.

Represented Fortune 100 companies in products matters involving alleged harm as a result of exposure to asbestos.  Jennifer has experience in handling all aspects of these cases and, as such, has secured dismissals or favorable settlements for her clients. 

Represented a Fortune 500 company in construction case involving violations of state labor laws.

Represented client in defense of misappropriation of trade secrets and conversion claims, leading to dismissal of case on appeal.

News

In the News · Source: Law.com, The Global Legal Post, Global Arbitration Review, IJGlobal, The Deal, Law360 Pulse, Australasian Lawyer, The Daily Report, Le Monde du Droit and La Lettre des Juristes d'Affaires

December 8, 2022
K&S elects 24 new partners and promotes 17 counsel across 15 cities

View all

Matters

Represents AstraZeneca Pharmaceuticals LP in coordinated California state court product liability cases related to treatment with Crestor®. 

Defends Bristol-Myers Squibb Company and AstraZeneca Pharmaceuticals LP in litigation in state and federal courts related to treatment with Onglyza®, a type 2 diabetes therapy.

Represented Fortune 100 companies in products matters involving alleged harm as a result of exposure to asbestos.  Jennifer has experience in handling all aspects of these cases and, as such, has secured dismissals or favorable settlements for her clients. 

See more
Icon close

Close

Matters

Represents AstraZeneca Pharmaceuticals LP in coordinated California state court product liability cases related to treatment with Crestor®. 

Defends Bristol-Myers Squibb Company and AstraZeneca Pharmaceuticals LP in litigation in state and federal courts related to treatment with Onglyza®, a type 2 diabetes therapy.

Represented Fortune 100 companies in products matters involving alleged harm as a result of exposure to asbestos.  Jennifer has experience in handling all aspects of these cases and, as such, has secured dismissals or favorable settlements for her clients. 

Represented a Fortune 500 company in construction case involving violations of state labor laws.

Represented client in defense of misappropriation of trade secrets and conversion claims, leading to dismissal of case on appeal.

News

In the News · Source: Law.com, The Global Legal Post, Global Arbitration Review, IJGlobal, The Deal, Law360 Pulse, Australasian Lawyer, The Daily Report, Le Monde du Droit and La Lettre des Juristes d'Affaires

December 8, 2022
K&S elects 24 new partners and promotes 17 counsel across 15 cities

View all

Credentials

J.D., Columbus School of Law

B.A., Boston University, cum laude

California

New Jersey

New York

U.S. District Court for the Central District of California

U.S. District Court for the District of New Jersey

U.S. District Court for the Southern District of New York